Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Wymann

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Transfusion|August 26, 2017
Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti-blood group A and B antibodies and individual susceptibilityOrell Mielke, Stefano Fontana, Vesselina Goranova-Marinova, et al.
Transfusion|July 16, 2015
Isoagglutinin reduction by a dedicated immunoaffinity chromatography step in the manufacturing process of human immunoglobulin productsLiane Hoefferer, Isabelle Glauser, Annette Gaida, et al.
Toxicology and Applied Pharmacology|December 8, 2024
Preclinical safety and efficacy of the recombinant CR1 drug product CSL040 in rats and cynomolgus monkeysTanja Ruthsatz, Sandra Wymann, Elena Velkoska, et al.
Scientific Reports|November 9, 2021
A potent truncated form of human soluble CR1 is protective in a mouse model of renal ischemia-reperfusion injuryAnjan K Bongoni, Ingela B Vikstrom, Jennifer L McRae, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2018
Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgECaroline Galeotti, Emmanuel Stephen-Victor, Anupama Karnam, et al.
Translational Stroke Research|April 23, 2024
Haptoglobin Attenuates Cerebrospinal Fluid Hemoglobin-Induced Neurological Deterioration in SheepBart R Thomson, Nina Schwendinger, Katrin Beckmann, et al.
The Biochemical Journal|April 26, 2022
Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivoSandra Wymann, Marcel Mischnik, David Leong, et al.
International Journal of Molecular Sciences|March 14, 2026
CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRnSandra Wymann, Rodrigo A V Morales, Wei Hong Toh, et al.
The Journal of Biological Chemistry|December 18, 2020
A novel soluble complement receptor 1 fragment with enhanced therapeutic potentialSandra Wymann, Yun Dai, Anup G Nair, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Transfusion|August 26, 2017
Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti-blood group A and B antibodies and individual susceptibilityOrell Mielke, Stefano Fontana, Vesselina Goranova-Marinova, et al.
Transfusion|July 16, 2015
Isoagglutinin reduction by a dedicated immunoaffinity chromatography step in the manufacturing process of human immunoglobulin productsLiane Hoefferer, Isabelle Glauser, Annette Gaida, et al.
Toxicology and Applied Pharmacology|December 8, 2024
Preclinical safety and efficacy of the recombinant CR1 drug product CSL040 in rats and cynomolgus monkeysTanja Ruthsatz, Sandra Wymann, Elena Velkoska, et al.
Scientific Reports|November 9, 2021
A potent truncated form of human soluble CR1 is protective in a mouse model of renal ischemia-reperfusion injuryAnjan K Bongoni, Ingela B Vikstrom, Jennifer L McRae, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2018
Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgECaroline Galeotti, Emmanuel Stephen-Victor, Anupama Karnam, et al.
Translational Stroke Research|April 23, 2024
Haptoglobin Attenuates Cerebrospinal Fluid Hemoglobin-Induced Neurological Deterioration in SheepBart R Thomson, Nina Schwendinger, Katrin Beckmann, et al.
The Biochemical Journal|April 26, 2022
Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivoSandra Wymann, Marcel Mischnik, David Leong, et al.
International Journal of Molecular Sciences|March 14, 2026
CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRnSandra Wymann, Rodrigo A V Morales, Wei Hong Toh, et al.
The Journal of Biological Chemistry|December 18, 2020
A novel soluble complement receptor 1 fragment with enhanced therapeutic potentialSandra Wymann, Yun Dai, Anup G Nair, et al.
Pageof 2